Work

Open label phase I study of MBP-426, a novel formulation of oxaliplatin, in patients with advanced or metastatic solid tumors.

Year: 2007

Type: article

Study design: Clinical Trial

Source: Molecular Cancer Therapeutics

Authors: Alexandria T. Phan, Chris H. Takimoto, Rosni Adinin, Leslie Wood, Henry Xiong, Kazuhiko Matsuno, Shuichiro Konno, Tadashi Fujisawa, Muralidhar Beeram

Institution: The University of Texas at San Antonio Health Science Center

Language: English

Topic: Nanoparticle-Based Drug Delivery

Subfield: Biomaterials

Field: Materials Science

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1922689830

FWCI: 0.149

Cites:

Cited by: 11

Related to: 10